Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal.Aristea announced the closing of a $63 million Series B financing led by Fidelity Management & Research…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
